IDEAS home Printed from https://ideas.repec.org/a/wly/hlthec/v5y1996i3p267-269.html
   My bibliography  Save this article

Using economics alongside clinical trials: Why we cannot choose the evaluation technique in advance

Author

Listed:
  • Cam Donaldson
  • Vanora Hundley
  • Emma McIntosh

Abstract

When drafting protocols for the use of economic evaluation alongside clinical trials, it is common to have to specify which type of economic evaluation is going to be carried out. Will it be a cost‐benefit analysis (CBA), cost‐effectiveness analysis (CEA) or a cost‐utility analysis (CUA)? It is our contention that prior specification of the appropriate economic technique is not possible, in the majority of cases, until data on effectiveness and cost are actually available. In this letter, we aim to demonstrate the thinking behind our contention and to illustrate this with two case studies; one of a recent randomised trial, the other of a trial currently in progress.

Suggested Citation

  • Cam Donaldson & Vanora Hundley & Emma McIntosh, 1996. "Using economics alongside clinical trials: Why we cannot choose the evaluation technique in advance," Health Economics, John Wiley & Sons, Ltd., vol. 5(3), pages 267-269, May.
    • Handle: RePEc:wly:hlthec:v:5:y:1996:i:3:p:267-269
    DOI: 10.1002/(SICI)1099-1050(199605)5:33.0.CO;2-X
    as

    Download full text from publisher

    File URL: https://doi.org/10.1002/(SICI)1099-1050(199605)5:33.0.CO;2-X
    Download Restriction: no
    File URL: https://libkey.io/10.1002/(SICI)1099-1050(199605)5:33.0.CO;2-X?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Andrew H. Briggs & Bernie J. O'Brien, 2001. "The death of cost‐minimization analysis?," Health Economics, John Wiley & Sons, Ltd., vol. 10(2), pages 179-184, March.
    2. Helen Dakin & Sarah Wordsworth, 2013. "Cost‐Minimisation Analysis Versus Cost‐Effectiveness Analysis, Revisited," Health Economics, John Wiley & Sons, Ltd., vol. 22(1), pages 22-34, January.
    3. John Hutton, 2012. "‘Health Economics’ and the evolution of economic evaluation of health technologies," Health Economics, John Wiley & Sons, Ltd., vol. 21(1), pages 13-18, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:hlthec:v:5:y:1996:i:3:p:267-269. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www3.interscience.wiley.com/cgi-bin/jhome/5749 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.